Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL R HINCKLEY

Allopathic & Osteopathic Physicians Dermatology

NPI
1760665707
CMS profile
1039974
Location
WEST JORDAN, UT

General Payments · PY2018–2024

$2,412.34

  • Reported across 138 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$529.37

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $529.37 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $153.78 10
ABBVIE INC. $133.09 13
UCB, Inc. $113.83 5
E.R. Squibb & Sons, L.L.C. $38.74 2
Amgen Inc. $33.76 2
Dermavant Sciences, Inc. $19.57 1
Arcutis Biotherapeutics, Inc. $18.85 1
Janssen Biotech, Inc. $17.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $381.58 23
PY2019 $403.54 21
PY2020 $189.00 11
PY2021 $522.25 24
PY2022 $146.67 10
PY2023 $239.93 14
PY2024 $529.37 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $1.51 02/01/2024 Food and Beverage Undisputed 01/23/2026 1103920677 CMS
ABBVIE INC. $15.63 02/01/2024 Food and Beverage Undisputed 01/23/2026 1103920679 CMS
ABBVIE INC. $4.11 02/19/2024 Food and Beverage Undisputed 01/23/2026 1103920681 CMS
ABBVIE INC. $18.10 05/16/2024 Food and Beverage Undisputed 01/23/2026 1103920683 CMS
ABBVIE INC. $15.55 06/20/2024 Food and Beverage Undisputed 01/23/2026 1103920685 CMS
ABBVIE INC. $9.41 07/01/2024 Food and Beverage Undisputed 01/23/2026 1103920687 CMS
ABBVIE INC. $14.68 07/16/2024 Food and Beverage Undisputed 01/23/2026 1103920689 CMS
ABBVIE INC. $13.94 08/12/2024 Food and Beverage Undisputed 01/23/2026 1103920691 CMS
ABBVIE INC. $18.33 09/26/2024 Food and Beverage Undisputed 01/23/2026 1103920693 CMS
ABBVIE INC. $1.59 09/26/2024 Food and Beverage Undisputed 01/23/2026 1103920695 CMS
ABBVIE INC. $8.89 10/15/2024 Food and Beverage Undisputed 01/23/2026 1103920697 CMS
ABBVIE INC. $4.01 11/23/2024 Food and Beverage Undisputed 01/23/2026 1103920699 CMS
ABBVIE INC. $7.34 12/17/2024 Food and Beverage Undisputed 01/23/2026 1103920701 CMS
Amgen Inc. $19.07 02/22/2024 Food and Beverage Undisputed 01/23/2026 1117277972 CMS
Amgen Inc. $14.69 08/08/2024 Food and Beverage Undisputed 01/23/2026 1117277974 CMS
Arcutis Biotherapeutics, Inc. $18.85 08/01/2024 Food and Beverage Undisputed 01/23/2026 1121064493 CMS
Dermavant Sciences, Inc. $19.57 03/15/2024 Food and Beverage Undisputed 01/23/2026 1127879305 CMS
E.R. Squibb & Sons, L.L.C. $21.32 06/13/2024 Food and Beverage Undisputed 01/23/2026 1101270253 CMS
E.R. Squibb & Sons, L.L.C. $17.42 11/14/2024 Food and Beverage Undisputed 01/23/2026 1101270289 CMS
Janssen Biotech, Inc. $17.75 02/29/2024 Food and Beverage Undisputed 01/23/2026 1078787870 CMS
Novartis Pharmaceuticals Corporation $19.87 01/04/2024 Food and Beverage Undisputed 01/23/2026 1086853043 CMS
Novartis Pharmaceuticals Corporation $15.34 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086853049 CMS
Novartis Pharmaceuticals Corporation $13.51 04/22/2024 Food and Beverage Undisputed 01/23/2026 1086853057 CMS
Novartis Pharmaceuticals Corporation $32.85 05/02/2024 Food and Beverage Undisputed 01/23/2026 1086853059 CMS
Novartis Pharmaceuticals Corporation $12.20 05/16/2024 Food and Beverage Undisputed 01/23/2026 1086853063 CMS
Novartis Pharmaceuticals Corporation $6.23 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086853065 CMS
Novartis Pharmaceuticals Corporation $18.90 07/18/2024 Food and Beverage Undisputed 01/23/2026 1086853071 CMS
Novartis Pharmaceuticals Corporation $12.58 09/16/2024 Food and Beverage Undisputed 01/23/2026 1086853079 CMS
Novartis Pharmaceuticals Corporation $2.68 10/31/2024 Food and Beverage Undisputed 01/23/2026 1086853083 CMS
Novartis Pharmaceuticals Corporation $19.62 10/31/2024 Food and Beverage Undisputed 01/23/2026 1086853085 CMS
UCB, Inc. $27.86 01/19/2024 Food and Beverage Undisputed 01/23/2026 1143055853 CMS
UCB, Inc. $16.60 03/07/2024 Food and Beverage Undisputed 01/23/2026 1143225730 CMS
UCB, Inc. $19.12 04/29/2024 Food and Beverage Undisputed 01/23/2026 1143225735 CMS
UCB, Inc. $23.60 08/07/2024 Food and Beverage Undisputed 01/23/2026 1143225739 CMS
UCB, Inc. $26.65 11/19/2024 Food and Beverage Undisputed 01/23/2026 1143225744 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.